Mary Litzinger
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Oncology 9
- Cancer Cells and Metastasis 7
- Cancer Immunotherapy and Biomarkers 2
-
- Immunotherapy and Immune Responses 6
- T-cell and B-cell Immunology 3
- Immune Cell Function and Interaction 2
- Co-authors
- Claudia Palena (13 shared papers)Romaine I. Fernando (11 shared papers)Duane H. Hamilton (9 shared papers)Jeffrey Schlom (10 shared papers)Marianne D. Castillo (1 shared paper)Paola Trono (1 shared paper)Douglas W. Grosenbach (2 shared papers)Tyler J. Curiel (1 shared paper)
- Journals
- Clinical Cancer Research (2 papers)Cancer Research (2 papers)Experimental Biology and Medicine (1 paper)The Journal of Urology (1 paper)Oncotarget (1 paper)
- Partner nations
- United StatesItalyUkraine
In The Last Decade
Mary Litzinger
15 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 71
- Oncology 644
- Immunology 515
- Cancer Research 162
- Rheumatology 132
- Pulmonary and Respiratory Medicine 231
Countries citing papers authored by Mary Litzinger
This map shows the geographic impact of Mary Litzinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Litzinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Litzinger more than expected).
Fields of papers citing papers by Mary Litzinger
This network shows the impact of papers produced by Mary Litzinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Litzinger. The network helps show where Mary Litzinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Mary Litzinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 319 | |
| 2 | 2010 | 206 | |
| 3 | 2007 | 151 | |
| 4 | 2007 | 127 | |
| 5 | 2012 | 102 | |
| 6 | 2007 | 95 | |
| 7 | 2013 | 68 | |
| 8 | 2014 | 62 | |
| 9 | 2013 | 54 | |
| 10 | 2012 | 37 | |
| 11 | 2005 | 34 | |
| 12 | 2011 | 26 | |
| 13 | 2008 | 13 | |
| 14 | 2010 | 7 | |
| 15 | 2013 | 1 |
About Mary Litzinger
Mary Litzinger is a scholar working on Oncology, Immunology, Cancer Research, Molecular Biology and Genetics, having authored 15 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (7 papers), Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immune Cell Function and Interaction (2 papers), Cancer-related molecular mechanisms research (2 papers) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Oncology (644 citations), Immunology (515 citations), Cancer Research (162 citations), Rheumatology (132 citations) and Pulmonary and Respiratory Medicine (231 citations). Mary Litzinger has collaborated with scholars based in United States, Italy and Ukraine. Frequent co-authors include Claudia Palena, Romaine I. Fernando, Duane H. Hamilton, Jeffrey Schlom, Marianne D. Castillo, Paola Trono, Douglas W. Grosenbach, Tyler J. Curiel, Kwong Y. Tsang and James W. Hodge. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Experimental Biology and Medicine, The Journal of Urology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.